Roche Chairman to Step Down in 2014
Franz B. Humer, chairman of the board of directors of the Roche Group, will not stand for re-election to the Board in 2014.
Franz B. Humer, chairman of the board of directors of the Roche Group, announced at the company’s March 5 annual general meeting that he will not stand for re-election to the Board in 2014. The company will nominate a successor for the chairmanship in autumn 2013.
The Roche Board has decided that Humer’s successor will also serve as non-executive Chairman, thus maintaining the established separation of the offices of Chairman and Chief Executive Officer, according to a company statement.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
